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Abstract
Objectives—To examine sociodemographic factors and chronic health conditions of people 
living with HIV (PLWHIV/HIV+) at least 65 years old and compare their chronic disease 
prevalence with beneficiaries without HIV.
Design—National fee-for-service Medicare claims data (parts A and B) from 2006 to 2009 were 
used to create a retrospective cohort of beneficiaries at least 65 years old.
Methods—Beneficiaries with an inpatient or skilled nursing facility claim, or outpatient claims 
with HIV diagnosis codes were considered HIV+. HIV+ beneficiaries were compared with 
uninfected beneficiaries on demographic factors and on the prevalence of hypertension, 
hyperlipidemia, ischemic heart disease, rheumatoid arthritis/osteoarthritis, and diabetes. Odds 
ratios (OR), 95% confidence intervals (CIs), and P values were calculated. Adjustment variables 
included age, sex, race/ethnicity, end stage renal disease (ESRD), and dual Medicare–Medicaid 
enrollment. Chronic conditions were examined individually and as an index from zero to all five 
conditions.
Results—Of 29 060 418 eligible beneficiaries, 24 735 (0.09%) were HIV+. HIV+ beneficiaries 
were more likely to be Hispanic, African-American, male, and younger (P > 0.0001) and were 
1.5–2.1 times as likely to have a chronic disease [diabetes (adjusted OR) 1.51, 95% CI (1.47, 
1.55):rheumatoid arthritis/osteoarthritis 2.14, 95% CI (2.08, 2.19)], and 2.4–7 times as likely to 
have 1–5 comorbid chronic conditions [1 condition (adjusted OR) 2.38, 95% CI (2.21, 2.57): 5 
conditions 7.07, 95% CI (6.61, 7.56)].
Conclusion—Our results show that PLWHIV at least 65 years old are at higher risk of 
comorbidities than other fee-for-service Medicare beneficiaries. This finding has implications for 
the cost and health management of PLWHIV 65 years and older.
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Recent epidemiologic reviews of people living with HIV (PLWHIV) in the United States 
have indicated that those at least 50 years old represent an increasing proportion of those 
infected [1]. In 2011, about 36% of all PLWHIV in the United States and six territories were 
persons at least 50 years of age [2]. This group of PLWHIV is expanding largely because of 
increased length of survival after HIV infection, rather than increased numbers of infections 
and diagnoses [1]. Survival time for PLWHIV has increased significantly since the 
introduction of HAART in 1996.
Recent cohort trials have indicated that PLWHIV now have a lifespan close to that of non-
HIV infected persons [3,4]. With appropriate antiretroviral management, it is expected that 
increasing numbers of PLWHIV will survive into older age, with some estimating that by 
2020, half of all PLWHIV will be at least 50 years old [5].
Research has begun to focus on the threats to health of older PLWHIV, both those due to 
normal aging processes, as well as those due to their HIV infection. There is evidence that 
older PLWHIV experience age-related illnesses earlier in life, or in a more severe form than 
their non-HIV infected counterparts [6]. It is hypothesized that the greater severity and 
earlier onset of these diseases may be due to the changes in immunity and inflammation 
caused by HIV infection [5]. PLWHIV appear to be more likely to suffer from classic age-
related comorbidities such as cardiovascular disease, diabetes, and renal failure than their 
noninfected, age-matched counterparts [7]. There are also concerns that HAART drug 
regimens may cause damage to the kidneys and liver in certain PLWHIV, and that drug 
toxicity could interact with age-related declines in organ function [8,9]. Many HAART 
drugs have also been associated with abnormal lipid profiles, which can increase the risk of 
cardiovascular diseases and diabetes [10,11]. It is also possible that PLWHIV are more 
prone to age-related chronic diseases due to high prevalence of harmful behaviors, such as 
substance abuse [12–14].
Despite recent attention on older PLWHIV, there is still the need for more specific and in-
depth research in this population. In particular, although many studies have included or even 
focused on persons at least 50 years of age, few studies have subdivided this category 
further, or included substantial numbers of persons at least 65 years of age [15,16]. 
According to the Centers for Disease Control and Prevention in 2010, there were an 
estimated 35 000 PLWHIV who were at least 65 years of age, a number that will only get 
larger in the coming years [2]. There is a lack of knowledge about the health of PLWHIV at 
least 65 years old compared with that of their non-HIV infected counterparts, including their 
prevalence of chronic diseases. The objective of this study is to examine sociodemographic 
factors and chronic health conditions of PLWHIVaged 65 years and older, and to compare 
their chronic disease prevalence with beneficiaries without HIV.
Methods
Americans at least 65 years of age almost universally receive their health insurance coverage 
from Medicare. During 2006–2009, the majority (84–77%) of Medicare beneficiaries were 
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fee-for-service (FFS) enrollees, making FFS claims a comprehensive source to investigate 
the health of PLWHIV at least 65 years old [17]. Inclusion criteria for this study were as 
follows: enrollment in parts A and B of Medicare excluding those enrolled in a Health 
Maintenance Organization (Medicare Advantage/Medicare managed care programs), 
enrollment of 11 continuous months or more (or death) during the years 2006–2009, and age 
range of 65–116 (inclusive) (Fig. 1). The minimum 11-month enrollment criteria, the 
inclusion of data from dead beneficiaries until their date of death, and the exclusion of 
persons enrolled in Health Maintenance Organizations are all practices recommended by the 
Chronic Condition Warehouse (CCW) for determining FFS beneficiaries [18]. The upper 
age limit was chosen to include all beneficiaries who were plausibly alive, whereas 
excluding beneficiaries who were dead but did not have a confirmed death date. All data 
were de-identified, and each individual was assigned a unique identifier by the Centers for 
Medicare & Medicaid Services (CMS) prior to analysis.
To determine which beneficiaries had HIV, we created an algorithm that used the presence of 
an International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis 
code (ICD-9-CM) or diagnosis related group code (DRG) for HIVor AIDS (IDC-9-CM 42–
44, V08, or 79.53; DRG 969–977 or DRG 488–490 for claims prior to September 2007). 
Beneficiaries were considered to have HIV if they had one inpatient, skilled nursing, or 
long-term care facility claim with an ICD-9-CM or DRG code indicating HIV; or two claims 
on different days from other therapy services (part B) or outpatient services with an ICD-9-
CM or DRG code indicating HIV over the course of one year. This algorithm is similar in 
methodology to that used by CCW to identify beneficiaries with chronic diseases, and is also 
similar, but does not duplicate the method CCW recently developed to identify beneficiaries 
with HIV/AIDS in future data releases [19,20]. Eligible persons without indications of HIV 
were referred to as HIV- or non-HIV- infected.
The prevalence of the five most common chronic health conditions in the Medicare 
population at least 65 years of age was investigated in those with and without HIV [21]. 
These conditions included hypertension, hyperlipidemia, ischemic heart disease, rheumatoid 
arthritis/osteoarthritis, and diabetes, as defined by CCW from the presence of ICD-9-CM 
diagnosis, Current Procedural Terminology Fourth Edition codes, or Healthcare Common 
Procedure Coding System codes [19]. Beneficiaries who met each chronic condition’s 
criteria were indicated by CCW before data analysis. These chronic condition variables are 
used in numerous publications from both CMS and in the general literature [21,22]. A list of 
the codes and specified reference periods that CCW uses to identify persons with 
hypertension, hyperlipidemia, ischemic heart disease, arthritis, and diabetes are included in 
the appendix, http://links.lww.com/QAD/A962.
The race/ethnicity of individuals were determined using the Research Triangle ‘corrected 
race ethnicity’ codes to allow for comparison to reports on chronic disease prevalences in 
Medicare issued by CMS [21]. Age was determined on the basis of birthdate and the date of 
enrollment, with beneficiaries only eligible for inclusion for the years when they were at 
least 65 years of age. Some CMS administrative variables were included in our analysis, 
including the original reason for qualifying in Medicare for persons enrolled before age 65 
[Social Security Administration declaration of disability, end stage renal disease (ESRD), or 
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both disability and ESRD], current reason for Medicare enrollment (age, disability, ESRD, 
or both disability and ESRD), Medicaid coverage start date (historical to January 1999), and 
months of dual enrollment in Medicaid and Medicare. Based on administrative summaries, 
we also were able to determine if a beneficiary had enrolled in optional Medicare part D 
prescription coverage during the course of the study.
All hypothesis testing was two-tailed, and P values of less than 0.05 were considered 
significant. To examine differences in sociodemographic factors and health conditions 
between HIV+ beneficiaries and their HIV- counterparts, Wald χ2 tests, Wilcoxon Z tests, 
and logistic regression modeling with odds ratios (ORs) and confidence intervals (CIs) were 
used. Models for chronic conditions were run both with and without adjustment for variables 
that are either commonly included in the chronic disease literature, or are known to affect 
the prevalence of chronic disease; including age, sex, and race/ethnicity, a measure of 
socioeconomic status, and ESRD [23–25]. In adjusted models, persons with missing values 
for any adjustment variables were dropped. Models examined the individual risk for each of 
the five chronic conditions among PLWHIV compared with non-HIV infected beneficiaries. 
In addition, an index was created to consider the number of comorbid chronic conditions 
from zero to five conditions (regardless of the combination of conditions). All statistical 
analyses were conducted using SAS statistical software, version 9.4 (SAS Institute Inc., 
Cary, North Carolina, USA).
Results
Approximately 29 million FFS Medicare beneficiaries met the inclusion criteria for the years 
2006–2009. Beneficiaries had varying year of enrollment depending on when they reached 
65 years of age, and on when they met FFS inclusion criteria. Out of all eligible persons, 
99.7% of beneficiaries without HIV and 99.5% of beneficiaries with HIV were eligible 
starting on 1 January 2006 and contributed four full years of data to this study. Of the 29 060 
418 eligible persons for this study, 99.9% were HIV−, and 24 735 (0.09%) were HIV+.
The median age of PLWHIV was about 5 years younger than their non-HIV infected 
counterparts (P value <0.0001). HIV+ beneficiaries were nearly twice as likely to be male, 
five times as likely to be African-American or Hispanic and were also more likely to live in 
Florida, New York, California, Texas, or New Jersey (Table 1). Beneficiaries with HIV 
infection were more likely to have had Medicaid coverage since 1999, OR 3.02, 95% CI 
(2.94, 3.10), to have had dual Medicaid and Medicare coverage for one or more months 
during the study, OR 3.19, 95% CI (3.11, 3.27), and to have enrolled in Medicare 
prescription coverage (Medicare Part D), OR 1.89, 95% CI (1.84, 1.94) than age-eligible 
persons without HIV infection. Beneficiaries with HIV infection were also more likely to 
have originally been eligible for Medicare via disability, OR 2.64, 95% CI (2.55, 2.72), 
ESRD, OR 6.46, 95% CI (5.18, 8.06), or both disability and ESRD, OR 5.57, 95% CI (4.22, 
7.35) (Table 1). PLWHIV were also approximately five times as likely to have the current 
reason for Medicare enrollment be listed as ESRD, OR 4.77, 95% CI (4.03, 5.66) but were 
about 60% less likely to die during the time of the study, OR 0.38, 95% CI (0.36, 0.40) 
(Table 1), a result partially due to the younger age of HIV+ beneficiaries (data not shown).
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HIV+ beneficiaries were approximately twice as likely as those without HIV infection to 
have chronic condition flags indicating hypertension, hyperlipidemia, ischemic heart 
disease, rheumatoid arthritis/osteoarthritis, or diabetes (Table 2). Adjusted risks for these 
chronic conditions ranged from aOR 1.51, 95% CI (1.47, 1.55) for diabetes to aOR 2.14, 
95% CI (2.08, 2.19) for rheumatoid arthritis/osteoarthritis (Table 3). Adjustment factors 
associated with HIV infection in multivariable models included being male, being of 
African-American race or Hispanic ethnicity, having ESRD, and dual eligibility for 
Medicaid and Medicare (Table 3). For male African-American and Hispanic beneficiaries 
with chronic conditions, the likelihood of HIV infection was especially elevated in 
comparison with that of white female beneficiaries with the same chronic condition, with 
aORs ranging from 8.99 to 6.33 (data not shown).
For models that examined the number of chronic diseases as an index, PLWHIV were more 
likely than their noninfected counterparts to have one or more chronic conditions, with 
increasing risks seen for each additional comorbidity. Although frequencies of having 2–4 
chronic conditions were similar for persons with and without HIV, HIV+ beneficiaries were 
less likely to have no chronic conditions or one chronic condition (13.22 vs. 25.66%) and 
were more likely to have five chronic conditions (22.11 vs. 8.41%) (Table 2). Adjusted odds 
of having HIV infection and one or more comorbidities ranged from aOR 2.38, 95% CI 
(2.21, 2.57) for having one condition to aOR 7.07, 95% CI (6.61, 7.56) for having all five 
chronic conditions (Table 4). Adjustment factors that were significant in each of the five 
individual models of chronic conditions remained significant in the model that considered 
the number of chronic conditions as an index. Male African-American and Hispanic 
beneficiaries were more than three times as likely to have HIV for each level of the chronic 
condition index as compared with white women with the same number of chronic conditions 
(data not shown).
Discussion
The current study found that age-eligible PLWHIV in Medicare were more likely to be of 
Hispanic ethnicity, African-American race, male sex, and younger than other age eligible 
Medicare beneficiaries. Beneficiaries with HIV infection were more likely to have originally 
enrolled in Medicare under disability benefits, to have been previously enrolled in Medicaid 
(since 1999), and to have been dually enrolled in Medicaid and Medicare. Beneficiaries with 
HIV infection were also more likely than those without HIV infection to have one or more 
of the five most common chronic health conditions, increasing the complexity of their 
medical issues, care, and likelihood of ill health after age 65.
Increasing numbers of PLWHIV will use Medicare as their primary source of insurance as 
survival of HIV-positive persons extends to 50 or more years postinfection [3,4]. Although 
historically Medicaid has been a major source of health insurance for PLWHIV, Medicaid is 
only responsible for insurance costs after all other third-party insurance payers, including 
Medicare, are billed for services [26]. As greater numbers of PLWHIV enter Medicare as 
age-eligible beneficiaries, the majority of their care costs will shift from Medicaid to 
Medicare [27]. This is important given that costs for HIV care are considerable, even 
without the additional costs seen when multiple chronic conditions are also considered. Cost 
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estimates of living with HIV in the United States range considerably depending on 
demographic and HIV-related factors; but estimates using 2005 and 2006 data range from 
$10 000 to $40 000 per year [28,29]. Costs associated with multiple chronic health problems 
are also high. Data from 2005 Medicare expenditure costs indicate that the annual costs for 
Medicare beneficiaries with one chronic condition are $7172, and for beneficiaries with 
three or more chronic conditions $32 498 [30].
The current study adds to the growing body of literature on older PLWHIV in the United 
States. Historically, PLWHIV have entered the Medicare health system as younger persons 
eligible for Medicare via social security disability benefits. However, with the aging HIV-
positive patient population, HIV providers in the Medicare network will have to prepare for 
patients with different medical needs, including a higher likelihood of chronic comorbid 
health conditions. Similarly, chronic disease practitioners who serve in the Medicare 
network, such as cardiologists and endocrinologists, should be aware that their Medicare 
patients may be receiving treatment for HIV infection. Greater collaboration between 
infectious disease and chronic disease practitioners will be needed to ensure the appropriate 
medical management of these patients including complex medication regimens [31,32].
The current study is the first and largest one to the authors’ knowledge to examine chronic 
conditions among PLWHIV who are exclusively 65 years of age or older. Previous studies 
have examined frequencies of chronic conditions among PLWHIV at least 50 years of age, 
but few of these studies have included large numbers of participants 65 years and older [33–
37]. This study is in agreement with many previous studies that have found higher 
prevalence of disease, or increased risk for cardiovascular diseases, arthritis, and diabetes 
among persons with HIV, both among those at least 50 years of age and those not focused on 
older persons with HIV [7,11,38].
The current study identified 24 735 FFS Medicare beneficiaries who were at least 65 years 
old with HIV infection, which represents 78% of the total number of PLWHIV at least 65 
years of age identified in the Centers for Disease Control and Prevention National 
surveillance data for 2009 [2]. The discrepancy between the number of PLWHIV identified 
in this study and in surveillance reports is likely due to the exclusion in this study of 
beneficiaries enrolled in Health Maintenance Organizations. During the years 2006–2009, 
16–23% of all Medicare beneficiaries were members of Medicare Advantage/managed care 
plans [17].
There are several limitations to this work. The time period of the study was restricted to the 
most recent available data for persons with dual Medicare–Medicaid benefits, which at the 
time of analysis was 2009. It is important to note that Medicare claims data are 
reimbursement based and contain only information for provided health services. Therefore, 
information on some demographic factors of interest (education level, income), results of 
clinical tests (viral load tests, CD4+ T-cell tests), and other patient history information (e.g. 
diet, exercise, and presence of risk behaviors such as smoking) were not available. This 
study also developed a novel algorithm for FFS Medicare beneficiaries with HIV. This 
algorithm was based on early formulations of the CCW other chronic or potentially 
disabling condition HIV flag. The CCW has recently finalized their HIV flag, but it has not 
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yet been retrospectively applied to historic data [20]. Whereas the codes used to define HIV
+ beneficiaries in this article and those used in the CCW algorithm are the same, there are 
slight differences between the algorithm in this article and that developed by the CCW. The 
number of claims needed for the CCW algorithm is two for all claim types except for 
inpatient, whereas this article considered one claim sufficient for all but outpatient and other 
therapy (part B) claims. Similarly, the CCW algorithm uses a 2-year retrospective period, 
whereas this article used a single year retrospective period. It is possible that the shorter 
retrospective period used in this article will underestimate the number of HIV+ beneficiaries 
in comparison with the algorithm used by CCW. In contrast, the fewer claims used in this 
article as compared with the CCW criteria may result in an overestimation of HIV+ 
beneficiaries.
This paper used CCW algorithms to determine who had chronic conditions. These 
algorithms are commonly used in the analysis of Medicare data but are known to be less 
sensitive in identifying diseases than the clinical medical record [39]. Some studies have 
indicated that the CCW algorithms are likely to underestimate chronic illnesses, especially 
those that may not require frequent medical care [40]. It is also possible that a higher 
proportion of chronic conditions that ordinarily do not require frequent medical care would 
be diagnosed among individuals with HIV who are adherent to care and regularly encounter 
medical professionals. In addition, astute healthcare personnel may have preferentially 
screened HIV-positive beneficiaries for particular chronic conditions known to be associated 
with long-term HIV infection and antiretroviral treatment, such as diabetes and 
cardiovascular diseases, leading to increased diagnosis of some chronic conditions among 
PLWHIV. Prevalence of both HIV and chronic conditions was measured in this article, not 
incidence. The temporal relationship between HIV infection and chronic conditions cannot 
be determined because of the lack of original clinical diagnosis dates. Survivor bias is likely 
to have affected the available Medicare beneficiary population, both those with and without 
HIV. Medicare prescription drug plans were only introduced in 2006 (part D), and not all 
beneficiaries in this study had prescription drug information available to researchers. This 
includes a lack of information on HAART, which is likely to influence chronic condition 
prevalence for HIV+ beneficiaries. Beneficiaries who had HIV infection and part D 
Medicare drug coverage will be explored in depth in a future analysis.
In conclusion, this is the first and largest study of PLWHIV at least 65 years old. Using an 
original data source, our results show that this population is at significantly higher risk of 
comorbidities than other non-HIV infected Medicare beneficiaries. Medicare data represent 
a rich source of information to create HIV-positive cohorts with information on multiple 
chronic conditions that affect older PLWHIV.
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Fig. 1. Inclusion criteria and number of eligible beneficiaries in Medicare 2006–2009
*HIV+ beneficiaries were those with International Classification of Diseases, Ninth 
Revision, Clinical Medication, or diagnosis related group codes with a diagnosis of HIV, 
HIV− were beneficiaries without these codes.
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Table 1
Demographics and Medicare coverage in beneficiaries at least 65 years old with and without HIV infectiona, 
2006–2009.
Sociodemographic factors (N = 29 060 
418)
HIV− median (SD) or 
number (%)
HIV+ median (SD) 
or number (%)
HIV+ vs. HIV− OR 
(95% CI)
Wilcoxon Z P 
value or Wald 
χ2 P value
Age 75.2 (+7.7)   71.1 (+6.3)   NA <0.0001
Sex
 Unknown 16 (0%)     0 (0%)     NA NA
 Maleb 12 203 017 (42.2%) 14 419 (58.3%) 1.93 (1.88, 1.98) <0.0001
 Femaleb 16 832 650 (58.0%) 10 316 (41.7%) Reference Reference
Race/ethnicity
 Unknown 29 196 (0.1%)  9 (0%)     0.57 (0.30, 1.03) 0.10  
 Non-Hispanic white 24 321 073 (83.8%) 13 068 (52.8%) Reference Reference
 African-American 2240 959 (7.7%)  6492 (26.3%) 5.39 (5.23, 5.56) <0.0001
 Other 154 649 (0.5%)  137 (0.6%)  1.65 (1.39, 1.95) <0.0001
 Asian/Pacific Islander 627 525 (2.2%)  338 (1.4%)  0.99 (0.89, 1.10) 0.96  
 Hispanic 1556 497 (5.4%)  4634 (18.7%) 5.51 (5.33, 5.70) <0.0001
 Native American 105 784 (0.4%)  57 (0.2%)  1.00 (0.90, 1.12) 0.98  
State of residence
 Any other state 20 048 783 (69.0%) 11 668 (47.2%) Reference Reference
 Florida 2068 065 (7.1%)  5402 (21.8%) 4.49 (4.34, 4.63) <0.0001
 New York 1738 310 (6.0%)  2443 (9.9%)  2.40 (2.30, 2.51) <0.0001
 California 23 525 562 (8.1%)  2432 (9.8%)  1.78 (1.71, 1.86) <0.0001
 Texas 1911 494 (6.6%)  1443 (5.8%)  1.30 (1.23, 1.37) <0.0001
 New Jersey 932 094 (3.2%)  1347 (5.5%)  2.48 (2.35,2.63) <0.0001
Died during study 6879 447 (23.7%) 2606 (10.5%) 0.38 (0.36, 0.40) <0.0001
Ever had Medicaid coveragec 6216 824 (21.4%) 11 164 (45.1%) 3.02 (2.94, 3.10) <0.0001
Had dual coveraged 5394 511 (18.6%) 10 418 (42.1%) 3.19 (3.11, 3.27) <0.0001
Had Medicare part D coverage 15 483 704 (53.3%) 16 898 (68.3%) 1.89 (1.84, 1.94) <0.0001
Original Medicare category
 Old age/survivors insurance 26 762 008 (92.2%) 20 150 (81.5%) Reference Reference
 Disability insurance benefits 2245 503 (7.7%)  4456 (18.0%) 2.64 (2.55, 2.72) <0.0001
 ESRD 16 243 (0.1%)  79 (0.3%)  6.46 (5.18, 8.06) <0.0001
 Both disability and renal 11 929 (0.0%)  50 (0.2%)  5.57 (4.22, 7.35) <0.0001
Current Medicare category
 Old age/survivors insurance 28 995 402 (99.9%) 24 594 (99.4%) Reference Reference
 Disability insurance benefits 7078 (0%)     7 (0%)     1.17 (0.56, 2.45) 0.68  
 ESRD 33 091 (0.1%)  134 (0.5%)  4.77 (4.03, 5.66) <0.0001
 Both disability and renal 112 (0%)     0 (0%)     NA 0.89  
CI, confidence interval; ESRD, end stage renal disease; OR, odds ratio.
a
HIV+ beneficiaries were those with ICD-9-CM, or DRG codes with a diagnosis of HIV, HIV− were beneficiaries without these codes.
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b
There were individuals whose sex response differed from their gender response, and two individuals whose sex and gender were both unknown.
c
Had a Medicaid coverage start date (historical to 1999).
d
Dual coverage was defined as having Medicaid and Medicare coverage for one or more months 2006–2009.
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Table 2
Prevalence and unadjusted odds ratios for each of the five chronic conditions and for the number of chronic 
conditions as an index in Medicare beneficiaries at least 65 years old with and without HIV infectiona.
Chronic conditionb (N = 29 060 418) HIV− number (%) HIV+ number (%) HIV+ vs. HIV− OR (95% CI)
Hypertension 21 460 895 (73.9%) 21 146 (85.5%)  2.08 (2.00, 2.15)
Hyperlipidemia 17 039 249 (58.7%) 17 759 (71.8%)  1.79 (1.74, 1.84)
Ischemic heart disease 13 476 065 (46.4%) 15 190 (601.4%) 1.84 (1.79, 1.89)
Rheumatoid/osteoarthritis 12 310 604 (42.4%) 14 277 (57.7%)  1.86 (1.81, 1.90)
Diabetes 9249 614 (31.9%) 12 181 (49.3%)  2.08 (2.02, 2.13)
Number of chronic conditionsc
 0 3646 397 (12.6%) 1030 (4.2%)    Reference
 1 3803 118 (13.1%) 2241 (9.1%)    2.09 (1.93, 2.25)
 2 5883 662 (20.3%) 3760 (15.2%)  2.26 (2.11, 2.42)
 3 7282 313 (25.1%) 5493 (22.2%)  2.67 (2.50, 2.85)
 4 5981 919 (20.6%) 6742 (27.3%)  3.99 (3.74, 4.26)
 5 2438 274 (8.4%)  5469 (22.1%)  7.94 (7.43, 8.49)
CI, confidence interval; OR, odds ratio.
a
HIV+ beneficiaries were those with ICD-9-CM, or DRG codes with a diagnosis of HIV, HIV− were beneficiaries without these codes.
b
Chronic health conditions were defined by ICD-9-CM, diagnosis or procedure codes, or HCPCS codes.
c
The number of chronic diseases as an index (regardless of the combination of conditions).
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Table 4
Adjusted odds ratios for the number of chronic conditions as an index among Medicare beneficiaries at least 
65 years old with HIV infectiona.
HIV+ vs. HIV− (N = 29 060 402) aOR (95% CI) Wald χ2 Pvalue
Number of chronic conditionsb
 0 Reference Reference
 1 2.38 (2.21, 2.57) <0.0001
 2 2.63 (2.46, 2.83) <0.0001
 3 2.98 (2.46, 2.83) <0.0001
 4 4.13 (3.87,4.41) <0.0001
 5 7.07 (6.61, 7.56) <0.0001
Sex
 Male 2.11 (2.06, 2.17) <0.0001
 Female Reference Reference
Age (for each year younger) 0.94 (0.93, 0.94) <0.0001
Race/ethnicity
 Unknown race 0.77 (0.40, 1.48) 0.43  
 Non-Hispanic white Reference Reference
 African-American 3.86 (3.75, 4.00) <0.0001
 Other race 1.16 (0.98, 1.37) 0.09  
 Asian/Pacific Islander 0.62 (0.60, 0.70) 0.18  
 Hispanic 3.41 (3.29, 3.54) <0.0001
 Native American 0.70 (0.54, 0.91) 0.007
 Had dual coverage 2.31 (2.24, 2.38) <0.0001
 ESRD 1.44 (1.23, 1.68) <0.0001
CI, confidence interval; ESRD, end stage renal disease; aOR, adjusted odds ratio.
a
HIV+ beneficiaries were those with ICD-9-CM, or DRG codes with a diagnosis of HIV, HIV− were beneficiaries without these codes.
b
Chronic health conditions were defined by ICD-9-CM, diagnosis or procedure codes, or HCPCS codes.
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